Corvus Pharmaceuticals, Inc. (CRVS)
25.10
-0.42
(-1.65%)
USD |
NASDAQ |
Jan 23, 16:00
25.19
+0.09
(+0.36%)
After-Hours: 20:00
Corvus Pharmaceuticals Research and Development Expense (TTM): 29.75M for Sept. 30, 2025
Research and Development Expense (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (TTM) Benchmarks
| Regeneron Pharmaceuticals, Inc. | 5.097B |
| Plus Therapeutics, Inc. | 7.624M |
| Geron Corp. | 81.32M |
| Jaguar Health, Inc. | 15.19M |
| Rapt Therapeutics, Inc. | 82.87M |